SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 323 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.96 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $36,907,000 | -21.1% | 242,889 | -38.1% | 0.98% | -17.3% |
| Q1 2019 | $46,751,000 | +72.3% | 392,243 | +57.7% | 1.19% | +54.9% |
| Q4 2018 | $27,140,000 | +137.5% | 248,691 | +251.5% | 0.77% | +237.3% |
| Q3 2018 | $11,429,000 | +222.9% | 70,761 | +164.3% | 0.23% | +212.3% |
| Q2 2018 | $3,539,000 | -35.1% | 26,772 | -78.0% | 0.07% | -21.5% |
| Q3 2017 | $5,457,000 | +234.8% | 121,758 | +151.8% | 0.09% | +244.4% |
| Q2 2017 | $1,630,000 | +61.9% | 48,363 | +42.1% | 0.03% | +92.9% |
| Q1 2017 | $1,007,000 | +197.1% | 34,027 | +175.0% | 0.01% | +250.0% |
| Q4 2016 | $339,000 | – | 12,375 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 1,195,000 | $142,432,000 | 6.16% |
| Casdin Capital, LLC | 305,000 | $36,353,000 | 3.99% |
| Eventide Asset Management | 845,168 | $100,736,000 | 3.47% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 436,000 | $51,967,000 | 3.26% |
| NEXTHERA CAPITAL LP | 21,270 | $2,535,000 | 3.08% |
| Camber Capital Management LP | 500,000 | $59,595,000 | 2.97% |
| Eversept Partners, LP | 83,574 | $9,961,185 | 2.91% |
| CADIAN CAPITAL MANAGEMENT, LP | 610,546 | $72,771,000 | 2.84% |
| RTW INVESTMENTS, LP | 338,199 | $40,310,000 | 2.75% |
| Cormorant Asset Management, LP | 300,000 | $35,757,000 | 2.42% |